DALI: Defining Antibiotic Levels in Intensive Care Unit Patients: Are Current -Lactam Antibiotic Doses Sufficient for Critically Ill Patients?

Autor: Roberts JA, Lipman J, Starr T, Wallis SC, Paul SK, Margarit Ribas A, De Waele JJ, De Crop L, Spapen H, Wauters J, Dugernier T, Jorens P, Dapper I, De Backer D, Taccone FS, Rello J, Ruano L, Afonso E, Alvarez Lerma F, Gracia Arnillas MP, Fernández F, Feijoo N, Bardolet N, Rovira A, Garro P, Colon D, Castillo C, Fernado J, Lopez MJ, Fernandez JL, Arribas AM, Teja JL, Ots E, Carlos Montejo J, Catalan M, Prieto I, Gonzalo G, Galvan B, Blasco MA, Meyer E, Del Nogal F, Vidaur L, Sebastian R, Garde PM, Martin Velasco Mdel M, Zaragoza Crespo R, Esperatti M, Torres A, Montravers P, Baldesi O, Dupont H, Mahjoub Y, Lasocki S, Constantin JM, Payen JF, Martin C, Albanese J, Malledant Y, Pottecher J, Lefrant JY, Jaber S, Joannes Boyau O, Orban C, Ostermann M, McKenzie C, Berry W, Smith J, Lei K, Rubulotta F, Gordon A, Brett S, Stotz M, Templeton M, Rhodes A, Ebm C, Moran C, Kaukonen KM, Pettilä V, Dimopoulos G, Koulenti D, Xristodoulou A, Theodorou V, Kouliatsis G, Sertaridou E, Anthopoulos G, Choutas G, Rantis T, Karatzas S, Balla M, Papanikolaou M, Myrianthefs P, Gavala A, Fildisis G, Koutsoukou A, Kyriakopoulou M, Petrochilou K, Kompoti M, Michalia M, Clouva Molyvdas FM, Gkiokas G, Nikolakopoulos F, Psychogiou V, Malliotakis P, Akoumianaki E, Lilitsis E, Koulouras V, Nakos G, Kalogirou M, Komnos A, Zafeiridis T, Chaintoutis C, Arvaniti K, Matamis D, Kydona C, Gritsi Gerogianni N, Giasnetsova T, Giannakou M, Soultati I, Chytas I, Antoniadou E, Antipa E, Lathyris D, Koukoubani T, Paraforou T, Spiropoulou K, Bekos V, Spring A, Kalatzi T, Nikolaou H, Laskou M, Strouvalis I, Aloizos S, Kapogiannis S, Soldatou O, Bassetti M, Adembri C, Villa G, Montalto F, Strano MT, Ranieri VM, Sandroni C, De Pascale G, Molin A, Pelosi P, Montagnani L, Urbino R, Mastromauro I, De Rosa FG, Cardoso T, Afonso S, Gonçalves Pereira J, Baptista JP, Akova M, Ozveren A., GIARRATANO, Antonino, RAINERI, Santi Maurizio, CORTEGIANI, Andrea

Publikováno v: Clinical Infectious Diseases
Clinical Infectious Diseases, Oxford University Press (OUP), 2014, 58 (8), pp.1072-1083. ⟨10.1093/cid/ciu027⟩

Background. Morbidity and mortality for critically ill patients with infections remains a global healthcare problem. We aimed to determine whether α-lactam antibiotic dosing in critically ill patients achieves concentrations associated with maximal

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ddae2151882d6ebafccb0193d12e0d0
https://hal.umontpellier.fr/hal-01954093

Do we need a change in transfusion strategy in patients with subarachnoidal hemorrage?

Autor: Valles Angulo, S, Gracia Arnillas, MP, Dot Jordana, I, Cuadrado Godia, E, Ois Santiago, A, Vasco Castaño, F, Muñoz Bermudez, R, Samper Sanchez, M, Vivas Diaz, E, Villalba Martinez, G

Publikováno v: Intensive Care Medicine Experimental; Dec2015 Supplement, Vol. 3, p1-1, 1p

[Management of infectious complications associated with coronavirus infection in severe patients admitted to ICU].

Autor: Estella Á; Servicio de Medicina Intensiva, Hospital Universitario de Jerez, Departamento de Medicina, Facultad de Medicina de Cádiz, Jerez de la Frontera, Cádiz, España., Vidal-Cortés P; Servicio de Medicina Intensiva, Complexo Hospitalario Universitario de Ourense, Ourense, España., Rodríguez A; Servicio de Medicina Intensiva, Hospital Universitario Joan XXIII de Tarragona, Tarragona, España., Andaluz Ojeda D; Servicio de Medicina Intensiva, Hospital Universitario de Sanchinarro de Madrid, Madrid, España., Martín-Loeches I; PhD JFICMI Consultant in Intensive Care Medicine, CLOD Dublin Midlands group, St James's University Hospital, Trinity Centre for Health Sciences, HRB-Welcome Trust St James's Hospital, Dublín, EIRE, Universidad de Barcelona, Barcelona, España., Díaz E; Servicio de Medicina Intensiva, Hospital Parc Tauli, Sabadell, España., Suberviola B; Servicio de Medicina Intensiva, Hospital Universitario Marqués de Valdecilla. Santander, España., Gracia Arnillas MP; Servicio de Medicina Intensiva, Hospital Universitario del Mar, Barcelona, España., Catalán González M; Servicio de Medicina Intensiva, Hospital Universitario 12 de Octubre, Madrid, España., Álvarez-Lerma F; Servicio de Medicina Intensiva, Parc de Salut Mar, Hospital del Mar, Barcelona, España., Ramírez P; Servicio de Medicina Intensiva, Hospital La Fe de Valencia, Valencia, España., Nuvials X; Servicio de Medicina Intensiva, Hospital Vall d'Hebrón, Barcelona, España., Borges M; Unidad Multidisciplinar de Sepsis, Servicio de Medicina Intensiva, Hospital Universitario Son Llatzer, IDISBA, Enfermedades Infecciosas UIB, Palma de Mallorca, Área de Sepsis e Infecciosas, Federación Ibérica y Panamericana de Medicina Intensiva (FEPIMCTI), Palma de Mallorca, España., Zaragoza R; Servicio de Medicina Intensiva, Hospital Universitario Dr. Peset, Valencia, España.

Publikováno v: Medicina intensiva [Med Intensiva] 2021 Nov; Vol. 45 (8), pp. 485-500. Date of Electronic Publication: 2021 Apr 30.

Risk Factors for Amoxicillin-Clavulanate Resistance in Community-Onset Urinary Tract Infections Caused by Escherichia coli or Klebsiella pneumoniae : The Role of Prior Exposure to Fluoroquinolones.

Autor: Martínez-Casanova J; Infectious Pathology and Antimicrobials Research Group (IPAR), Pharmacy Department, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Hospital del Mar, 08003 Barcelona, Spain., Gómez-Zorrilla S; Infectious Pathology and Antimicrobials Research Group (IPAR), Infectious Diseases Department, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Universitat Autònoma de Barcelona (UAB), CEXS-Universitat Pompeu Fabra, Hospital del Mar, 08003 Barcelona, Spain., Prim N; Microbiology Service, Infectious Pathology and Antimicrobials Research Group (IPAR), Laboratoi de Referència de Catalunya, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Universitat Autònoma de Barcelona (UAB), CEXS-Universitat Pompeu Fabra, Hospital del Mar, 08003 Barcelona, Spain., Dal Molin A; Infectious Pathology and Antimicrobials Research Group (IPAR), Infectious Diseases Department, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Universitat Autònoma de Barcelona (UAB), CEXS-Universitat Pompeu Fabra, Hospital del Mar, 08003 Barcelona, Spain., Echeverría-Esnal D; Infectious Pathology and Antimicrobials Research Group (IPAR), Pharmacy Department, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Hospital del Mar, 08003 Barcelona, Spain., Gracia-Arnillas MP; Critical Care Department, GREPAC, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Hospital del Mar, 08003 Barcelona, Spain., Sendra E; Infectious Pathology and Antimicrobials Research Group (IPAR), Infectious Diseases Department, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Universitat Autònoma de Barcelona (UAB), CEXS-Universitat Pompeu Fabra, Hospital del Mar, 08003 Barcelona, Spain., Güerri-Fernández R; Infectious Pathology and Antimicrobials Research Group (IPAR), Infectious Diseases Department, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Universitat Autònoma de Barcelona (UAB), CEXS-Universitat Pompeu Fabra, Hospital del Mar, 08003 Barcelona, Spain., Durán-Jordà X; Scientific, Statistics and Technical Department, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Hospital del Mar, 08003 Barcelona, Spain., Padilla E; Microbiology Service, Infectious Pathology and Antimicrobials Research Group (IPAR), Laboratoi de Referència de Catalunya, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Universitat Autònoma de Barcelona (UAB), CEXS-Universitat Pompeu Fabra, Hospital del Mar, 08003 Barcelona, Spain., Horcajada JP; Infectious Pathology and Antimicrobials Research Group (IPAR), Infectious Diseases Department, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Universitat Autònoma de Barcelona (UAB), CEXS-Universitat Pompeu Fabra, Hospital del Mar, 08003 Barcelona, Spain., Grau S; Infectious Pathology and Antimicrobials Research Group (IPAR), Pharmacy Department, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Hospital del Mar, 08003 Barcelona, Spain., Proa-Psmar Group OBOT

Publikováno v: Antibiotics (Basel, Switzerland) [Antibiotics (Basel)] 2021 May 14; Vol. 10 (5). Date of Electronic Publication: 2021 May 14.

Impact of adrenomedullin levels on clinical risk stratification and outcome in subarachnoid haemorrhage.

Autor: Gracia Arnillas MP; Critical Care Department, IMIM- Hospital del Mar, Barcelona, Spain.; IMIM (Medical Research Mar Institute), IMIM- Hospital del Mar, Barcelona, Spain., Alvarez-Lerma F; Critical Care Department, IMIM- Hospital del Mar, Barcelona, Spain.; IMIM (Medical Research Mar Institute), IMIM- Hospital del Mar, Barcelona, Spain., Masclans JR; Critical Care Department, IMIM- Hospital del Mar, Barcelona, Spain.; IMIM (Medical Research Mar Institute), IMIM- Hospital del Mar, Barcelona, Spain., Roquer J; Department of Neurology, Neurovascular Research Group, IMIM- Hospital del Mar, Barcelona, Spain., Soriano C; IMIM (Medical Research Mar Institute), IMIM- Hospital del Mar, Barcelona, Spain., Manzano D; Neurosurgery Department, Parc de Salut Mar, Hospital del Mar, Barcelona, Spain., Zapatero A; Critical Care Department, IMIM- Hospital del Mar, Barcelona, Spain.; IMIM (Medical Research Mar Institute), IMIM- Hospital del Mar, Barcelona, Spain., Diaz Y; Critical Care Department, IMIM- Hospital del Mar, Barcelona, Spain.; IMIM (Medical Research Mar Institute), IMIM- Hospital del Mar, Barcelona, Spain., Duran X; AMIB Methodological and Biostatistical Advice IMIM, IMIM- Hospital del Mar, Barcelona, Spain., Castellví A; Critical Care Department, IMIM- Hospital del Mar, Barcelona, Spain., Cuadrado E; Department of Neurology, Neurovascular Research Group, IMIM- Hospital del Mar, Barcelona, Spain., Ois A; Department of Neurology, Neurovascular Research Group, IMIM- Hospital del Mar, Barcelona, Spain.

Publikováno v: European journal of clinical investigation [Eur J Clin Invest] 2020 Nov; Vol. 50 (11), pp. e13318. Date of Electronic Publication: 2020 Jul 13.